Approximately 1.2 billion will be available for the lower-income economies participating in the COVAX Advance Market Commitment (AMC).
facility plans to supply 1.425 Billion doses of covid-19 vaccines in 2021. This is according to the forecast released on
doses, approximately 1.2 billion will be available for the lower-income
economies participating in the COVAX Advance Market Commitment (AMC).
a statement, if this is achieved it will be enough to protect 20% of the
population, or 40% of all adults, in all 92 economies except India. Over 200
million doses will be allocated to self-financing participants.
COVAX milestone of two billion doses released for delivery is now expected to
be reached in the first quarter of 2022 since already 240 million doses
have been delivered to 139 countries in just six months.
for countries that have achieved high vaccine coverage to step back comes
when only 20% of people in low- and lower-middle-income countries have
received a first dose of vaccine compared to 80% in high- and upper-middle-income
In the critical months during which COVAX was created, signed on participants,
pooled demand, and raised enough money to make advance purchases of vaccines,
much of the early global supply had already been bought by wealthy nations.
Today, COVAX’s ability to reach out to as many vulnerable people in the world, as
the statement shows is hampered by export bans, the prioritization of bilateral
deals by manufacturers and countries, ongoing challenges in scaling up
production by some key producers, and delays in filing for regulatory approval.
to working closely with participating governments to ensure the conditions are
in place on the ground to facilitate the successful rollout of vaccines, they
call on donors and manufacturers to recommit their support by not just giving
them priority in purchase orders but even for manufacturers
to be transparent on timelines for availability to COVAX to allow
countries to plan.